Literature DB >> 20971775

Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension.

Jens Vogel-Claussen1, Jan Skrok, Monda L Shehata, Sukhminder Singh, Christopher T Sibley, Danielle M Boyce, Noah Lechtzin, Reda E Girgis, Steven C Mathai, Thomas A Goldstein, Jie Zheng, João A C Lima, David A Bluemke, Paul M Hassoun.   

Abstract

PURPOSE: To evaluate the relationships of right ventricular (RV) and left ventricular (LV) myocardial perfusion reserves with ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension (PAH) by using adenosine stress perfusion cardiac magnetic resonance (MR) imaging.
MATERIALS AND METHODS: This HIPAA-compliant study was institutional review board approved. Twenty-five patients known or suspected to have PAH underwent right heart catheterization and adenosine stress MR imaging on the same day. Sixteen matched healthy control subjects underwent cardiac MR imaging only. RV and LV perfusion values at rest and at adenosine-induced stress were calculated by using the Fermi function model. The MR imaging-derived RV and LV functional data were calculated by using dedicated software. Statistical testing included Kruskal-Wallis tests for continuous data, Spearman rank correlation tests, and multiple linear regression analyses.
RESULTS: Seventeen of the 25 patients had PAH: 11 with scleroderma-associated PAH, and six with idiopathic PAH. The remaining eight patients had scleroderma without PAH. The myocardial perfusion reserve indexes (MPRIs) in the PAH group (median RV MPRI, 1.7 [25th-75th percentile range, 1.3-2.0]; median LV MPRI, 1.8 [25th-75th percentile range, 1.6-2.1]) were significantly lower than those in the scleroderma non-PAH (median RV MPRI, 2.5 [25th-75th percentile range, 1.8-3.9] [P = .03]; median LV MPRI, 4.1 [25th-75th percentile range, 2.6-4.8] [P = .0003]) and control (median RV MPRI, 2.9 [25th-75th percentile range, 2.6-3.6] [P < .01]; median LV MPRI, 3.6 [25th-75th percentile range, 2.7-4.1] [P < .01]) groups. There were significant correlations between biventricular MPRI and both mean pulmonary arterial pressure (mPAP) (RV MPRI: ρ = -0.59, Bonferroni P = .036; LV MPRI: ρ = -0.79, Bonferroni P < .002) and RV stroke work index (RV MPRI: ρ = -0.63, Bonferroni P = .01; LV MPRI: ρ = -0.75, Bonferroni P < .002). In linear regression analysis, mPAP and RV ejection fraction were independent predictors of RV MPRI. mPAP was an independent predictor of LV MPRI.
CONCLUSION: Biventricular vasoreactivity is significantly reduced with PAH and inversely correlated with RV workload and ejection fraction, suggesting that reduced myocardial perfusion reserve may contribute to RV dysfunction in patients with PAH. © RSNA, 2010

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971775      PMCID: PMC3009386          DOI: 10.1148/radiol.10100725

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  36 in total

1.  Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure.

Authors:  Norbert F Voelkel; Robert A Quaife; Leslie A Leinwand; Robyn J Barst; Michael D McGoon; Daniel R Meldrum; Jocelyn Dupuis; Carlin S Long; Lewis J Rubin; Frank W Smart; Yuichiro J Suzuki; Mark Gladwin; Elizabeth M Denholm; Dorothy B Gail
Journal:  Circulation       Date:  2006-10-24       Impact factor: 29.690

2.  Right coronary artery flow impairment in patients with pulmonary hypertension.

Authors:  Serge A van Wolferen; J Tim Marcus; Nico Westerhof; Marieke D Spreeuwenberg; Koen M J Marques; Jean G F Bronzwaer; Ivo R Henkens; C Tji-Joong Gan; Anco Boonstra; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2007-12-08       Impact factor: 29.983

3.  Fast mapping of myocardial blood flow with MR first-pass perfusion imaging.

Authors:  Thomas A Goldstein; Michael Jerosch-Herold; Bernd Misselwitz; Haosen Zhang; Robert J Gropler; Jie Zheng
Journal:  Magn Reson Med       Date:  2008-06       Impact factor: 4.668

4.  Effect of distal embolization on myocardial perfusion reserve after percutaneous coronary intervention: a quantitative magnetic resonance perfusion study.

Authors:  Joseph B Selvanayagam; Adrian S H Cheng; Michael Jerosch-Herold; Kazem Rahimi; Italo Porto; William van Gaal; Keith M Channon; Stefan Neubauer; Adrian P Banning
Journal:  Circulation       Date:  2007-09-04       Impact factor: 29.690

Review 5.  Epidemiology of pulmonary arterial hypertension.

Authors:  Darren B Taichman; Jess Mandel
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

6.  Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis.

Authors:  Gian Paolo Bezante; Daniela Rollando; Marta Sessarego; Nicoletta Panico; Maurizio Setti; Gilberto Filaci; Giuseppe Molinari; Manrico Balbi; Maurizio Cutolo; Antonio Barsotti; Francesco Indiveri; Massimo Ghio
Journal:  J Rheumatol       Date:  2007-11-01       Impact factor: 4.666

7.  Right ventricular wall "ischemia" findings using a dual isotope protocol.

Authors:  Ivana Moura Abuhid; Nilton Alves de Rezende
Journal:  Clin Nucl Med       Date:  2007-08       Impact factor: 7.794

8.  k-Space and time sensitivity encoding-accelerated myocardial perfusion MR imaging at 3.0 T: comparison with 1.5 T.

Authors:  Sven Plein; Juerg Schwitter; Daniel Suerder; John P Greenwood; Peter Boesiger; Sebastian Kozerke
Journal:  Radiology       Date:  2008-11       Impact factor: 11.105

Review 9.  Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies.

Authors:  Yannick Allanore; Christophe Meune; André Kahan
Journal:  Curr Opin Rheumatol       Date:  2008-11       Impact factor: 5.006

10.  Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.

Authors:  Birger Wolff; Sven Lodziewski; Tom Bollmann; Christian F Opitz; Ralf Ewert
Journal:  Am Heart J       Date:  2007-06       Impact factor: 4.749

View more
  40 in total

Review 1.  Redefining the role of cardiovascular imaging in patients with pulmonary arterial hypertension.

Authors:  Benjamin H Freed; Amit R Patel; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 2.  The right ventricle and pulmonary hypertension.

Authors:  Mariëlle C van de Veerdonk; Harm J Bogaard; Norbert F Voelkel
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

3.  Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension.

Authors:  Lian Tian; Monica Neuber-Hess; Jeffrey Mewburn; Asish Dasgupta; Kimberly Dunham-Snary; Danchen Wu; Kuang-Hueih Chen; Zhigang Hong; Willard W Sharp; Shelby Kutty; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2017-03-06       Impact factor: 4.599

Review 4.  Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis.

Authors:  Theodoros Dimitroulas; Sophie Mavrogeni; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2012-02-07       Impact factor: 20.543

Review 5.  Right ventricular adaptation and failure in pulmonary arterial hypertension.

Authors:  John J Ryan; Jessica Huston; Shelby Kutty; Nathan D Hatton; Lindsay Bowman; Lian Tian; Julia E Herr; Amer M Johri; Stephen L Archer
Journal:  Can J Cardiol       Date:  2015-01-29       Impact factor: 5.223

6.  The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension.

Authors:  Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405

Review 7.  The right ventricle in scleroderma (2013 Grover Conference Series).

Authors:  Paul M Hassoun
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

Review 8.  The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.

Authors:  John J Ryan; Stephen L Archer
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 9.  The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema.

Authors:  R Graham Barr
Journal:  Proc Am Thorac Soc       Date:  2011-11

10.  Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.

Authors:  Rachel Damico; Todd M Kolb; Lidenys Valera; Lan Wang; Traci Housten; Ryan J Tedford; David A Kass; Nicholas Rafaels; Li Gao; Kathleen C Barnes; Raymond L Benza; James L Rand; Rizwan Hamid; James E Loyd; Ivan M Robbins; Anna R Hemnes; Wendy K Chung; Eric D Austin; M Bradley Drummond; Stephen C Mathai; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2015-01-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.